|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ABII 10-K filed Mar 12, 2010. Collaborative Agreements and Other Licensing Obligations We have entered into various collaborative agreements under which we have agreed to provide funding to academic and clinical trial organizations of up to $53.8 million for research and other projects over a period of time of up to five years. Although we cannot predict the timing, we generally can control the timing and amount of spending as the projects require our approval in advance of funding. These excerpts taken from the ABII 10-K filed Mar 6, 2009. Collaborative Agreements and Other Licensing Obligations We have entered into various collaborative agreements under which we have agreed to provide funding to academic and clinical trial organizations of up to $65.5 million for research and other projects over a period of time of up to five years. Although we cannot predict the timing, we generally can control the timing and amount of spending as the projects require our approval in advance of funding. Collaborative Agreements and Other Licensing Obligations STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%">We have entered into various collaborative agreements under which we have agreed to provide funding to academic and clinical trial organizations of up to$65.5 million for research and other projects over a period of time of up to five years. Although we cannot predict the timing, we generally can control the timing and amount of spending as the projects require our approval in advance of funding. These excerpts taken from the ABII 10-K filed Mar 31, 2008. Collaborative Agreements and Other Licensing Obligations We have entered into various collaborative agreements under which we have agreed to provide funding to academic and clinical trial organizations of up to $65.2 million for research and other projects over a period of time of up to six years. Although we cannot predict the timing, we generally can control the timing and amount of spending as the projects require our approval in advance of funding. Collaborative Agreements and Other Licensing Obligations STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%">We have entered into various collaborative agreements under which we have agreed to provide funding to academic and clinical trial organizations of up to$65.2 million for research and other projects over a period of time of up to six years. Although we cannot predict the timing, we generally can control the timing and amount of spending as the projects require our approval in advance of funding. | EXCERPTS ON THIS PAGE:
|
| |||||||